209 related articles for article (PubMed ID: 27317864)
1. Mathematical model of tumor-immune surveillance.
Mahasa KJ; Ouifki R; Eladdadi A; Pillis L
J Theor Biol; 2016 Sep; 404():312-330. PubMed ID: 27317864
[TBL] [Abstract][Full Text] [Related]
2. A validated mathematical model of cell-mediated immune response to tumor growth.
de Pillis LG; Radunskaya AE; Wiseman CL
Cancer Res; 2005 Sep; 65(17):7950-8. PubMed ID: 16140967
[TBL] [Abstract][Full Text] [Related]
3. Death ligands and granulysin: mechanisms of tumor cell death induction and therapeutic opportunities.
Martinez-Lostao L; de Miguel D; Al-Wasaby S; Gallego-Lleyda A; Anel A
Immunotherapy; 2015; 7(8):883-2. PubMed ID: 26314314
[TBL] [Abstract][Full Text] [Related]
4. Reciprocal regulation between natural killer cells and autoreactive T cells.
Shi FD; Van Kaer L
Nat Rev Immunol; 2006 Oct; 6(10):751-60. PubMed ID: 16998508
[TBL] [Abstract][Full Text] [Related]
5. [New insights into cytotoxic effector cells].
Rey J; Olive D; Sébahoun G; O'Callaghan T; Costello RT
Bull Cancer; 2005 Nov; 92(11):935-43. PubMed ID: 16316827
[TBL] [Abstract][Full Text] [Related]
6. Natural killer cell immune escape in acute myeloid leukemia.
Lion E; Willemen Y; Berneman ZN; Van Tendeloo VF; Smits EL
Leukemia; 2012 Sep; 26(9):2019-26. PubMed ID: 22446501
[TBL] [Abstract][Full Text] [Related]
7. Cancer immunotherapy by interleukin-21: potential treatment strategies evaluated in a mathematical model.
Cappuccio A; Elishmereni M; Agur Z
Cancer Res; 2006 Jul; 66(14):7293-300. PubMed ID: 16849579
[TBL] [Abstract][Full Text] [Related]
8. Bidirectional interactions of NK cells and dendritic cells in immunotherapy: current and future perspective.
Mahmood S; Upreti D; Sow I; Amari A; Nandagopal S; Kung SK
Immunotherapy; 2015; 7(3):301-8. PubMed ID: 25804481
[TBL] [Abstract][Full Text] [Related]
9. Random migration contributes to cytotoxicity of activated CD8+ T-lymphocytes but not NK cells.
Onishi H; Kiyota A; Koya N; Tanaka H; Umebayashi M; Katano M; Morisaki T
Anticancer Res; 2014 Aug; 34(8):3947-56. PubMed ID: 25075016
[TBL] [Abstract][Full Text] [Related]
10. Mathematical modeling of the effect of boosting tumor infiltrating lymphocyte in immunotherapy.
Kartono A; Subiyanto
Pak J Biol Sci; 2013 Oct; 16(20):1095-103. PubMed ID: 24506008
[TBL] [Abstract][Full Text] [Related]
11. IL-15: targeting CD8+ T cells for immunotherapy.
Diab A; Cohen AD; Alpdogan O; Perales MA
Cytotherapy; 2005; 7(1):23-35. PubMed ID: 16040381
[TBL] [Abstract][Full Text] [Related]
12. Natural killer cells: the journey from puzzles in biology to treatment of cancer.
Bodduluru LN; Kasala ER; Madhana RM; Sriram CS
Cancer Lett; 2015 Feb; 357(2):454-67. PubMed ID: 25511743
[TBL] [Abstract][Full Text] [Related]
13. [NK cell-based immunotherapy: new prospects and involvement of dendritic cells].
Borg C; Taieb J; Terme M; Maruyama K; Flament C; Angevin E; Zitvogel L
Bull Cancer; 2003; 90(8-9):699-705. PubMed ID: 14609759
[TBL] [Abstract][Full Text] [Related]
14. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
[TBL] [Abstract][Full Text] [Related]
15. NK cells: innate immunity against hematological malignancies?
Costello RT; Fauriat C; Sivori S; Marcenaro E; Olive D
Trends Immunol; 2004 Jun; 25(6):328-33. PubMed ID: 15145323
[TBL] [Abstract][Full Text] [Related]
16. Multiple roles for CD4+ T cells in anti-tumor immune responses.
Kennedy R; Celis E
Immunol Rev; 2008 Apr; 222():129-44. PubMed ID: 18363998
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of T cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells (Review).
Hoskin DW; Mader JS; Furlong SJ; Conrad DM; Blay J
Int J Oncol; 2008 Mar; 32(3):527-35. PubMed ID: 18292929
[TBL] [Abstract][Full Text] [Related]
18. A mathematical model of cell-mediated immune response to tumor.
Song G; Tian T; Zhang X
Math Biosci Eng; 2020 Dec; 18(1):373-385. PubMed ID: 33525097
[TBL] [Abstract][Full Text] [Related]
19. NK and CD8+ T cell-mediated eradication of poorly immunogenic B16-F10 melanoma by the combined action of IL-12 gene therapy and 4-1BB costimulation.
Xu D; Gu P; Pan PY; Li Q; Sato AI; Chen SH
Int J Cancer; 2004 Apr; 109(4):499-506. PubMed ID: 14991570
[TBL] [Abstract][Full Text] [Related]
20. MHC class I antigens, immune surveillance, and tumor immune escape.
Garcia-Lora A; Algarra I; Garrido F
J Cell Physiol; 2003 Jun; 195(3):346-55. PubMed ID: 12704644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
